Phase 2 Hearing Loss Trial, Recruiting NCT06340633 Sponsor: Sound Pharmaceuticals, Incorporated Condition: Hearing Loss
Back to Hearing Loss

Phase 2 Hearing Loss Trial, Recruiting

NCT06340633
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of signing up for the trial
  • You developed hearing loss after you had already learned to speak, and you have moderate to severe or profound hearing loss in both ears that affects certain sound frequencies in a specific pattern (confirm with trial site)
  • You are already scheduled to receive a specific type of long cochlear implant (from MED-EL) in one ear
  • Your hearing test results in the ear being implanted show that you can still hear some lower-pitched sounds but have significant loss at higher pitches (confirm with trial site)
  • Your eardrum and middle ear are working normally in the ear being implanted, based on a standard ear pressure test
  • You are willing and able to give your consent to participate and complete all required hearing tests throughout the study, including meeting certain reproductive health requirements (confirm with trial site)

Who may not be able to join:

  • You are currently using, or have used in the past 60 days, certain strong medications given through a drip (IV) that can damage hearing, such as some chemotherapy drugs, certain antibiotics, or certain water pills (diuretics)
  • You have taken part in another research study involving an experimental drug or device within the past 90 days
  • You are currently pregnant or breastfeeding
  • You have moderate or severe liver disease, as measured by a standard medical scoring system
  • You have no measurable hearing response at three or more consecutive high-pitched sound frequencies in the ear being implanted
  • You have no movement in your middle ear, or your middle ear pressure is outside the normal range, based on an ear pressure test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 2066342559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Sound Pharmaceuticals, Incorporated
Registry
ClinicalTrials.gov
Start date
1 December 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Participants with Treatment Emergent Adverse Events (TEAE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov